Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep;30(9):666-73.
doi: 10.1097/MPH.0b013e31817e4a44.

The performance of the PedsQL generic core scales in children with sickle cell disease

Affiliations

The performance of the PedsQL generic core scales in children with sickle cell disease

Julie A Panepinto et al. J Pediatr Hematol Oncol. 2008 Sep.

Abstract

The objective of this study was to determine the feasibility, reliability, and validity of the Pediatric Quality of Life Inventory generic core scales (PedsQL questionnaire) in children with sickle cell disease. This was a cross-sectional study of children from an urban hospital-based sickle cell disease clinic and an urban primary care clinic. The study participants were children of ages 2 to 18 years who presented to clinic for a routine visit. Health-related quality of life (HRQL) was the main outcome. HRQL of children with sickle cell disease were compared with children without disease to test validity. Missing items were used to determine feasibility and Cronbach's alpha was used to determine reliability. Parents of 178 children (104 with sickle cell disease and 74 without disease) and 118 children (78 with sickle cell disease and 40 without disease) completed HRQL questionnaires. The PedsQL questionnaire was feasible and reliable. The parent proxy and child self-report questionnaire differentiated between children with and without sickle cell disease. The parent proxy-report differentiated well between children with mild and severe sickle cell disease. The questionnaire performed well in children with sickle cell disease and is a feasible, reliable, and valid tool to measure HRQL in children with sickle cell disease.

PubMed Disclaimer

References

    1. Fayers PM, Hays RD. Assessing quality of life in clinical trials : methods and practice. xiii. Oxford; New York: Oxford University Press; 2005. p. 467.
    1. Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott Williams and Wilkins; 1996.
    1. Trust SACotMO. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11(3):193–205. - PubMed
    1. CDER2002193 dnD- Draft Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. - PMC - PubMed
    1. Palermo TM, Schwartz L, Drotar D, et al. Parental report of health-related quality of life in children with sickle cell disease. J Behav Med. 2002;25(3):269–283. - PubMed

Publication types